Recruiting

Observational Study

Sponsor:

University Health Network, Toronto

Code:

NCT02298439

Conditions

Non-Alcoholic Fatty Liver Disease

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Study Details

Brief summary:

The purpose of the Non-Alcoholic Fatty Liver Disease (NAFLD) registry is to collect demographic and clinical data on patients being treated for NAFLD and to determine the factors affecting the progression of the disease as well as the success of different treatment strategies.

Conditions

Non-Alcoholic Fatty Liver Disease

Study ID

NCT02298439

Start date

Oct, 2013

Status verified date

Nov, 2022

Completion date

Jun, 2026

Anticipated

Primary completion date

Jun, 2026

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Inclusion Criteria:

- Patients being treated for NAFLD at the Toronto General Hospital NAFLD clinic

Exclusion Criteria:

  • None

Study Design

Enrollment

100 participants

Anticipated

Interventions and Outcome Measures

Primary outcome measure

  • Disease categorization [ Time Frame: Baseline ]

Central Contacts and Locations

Central contacts

Anastasia Teterina, PhD

416-340-4104anastasia.teterina@uhnresearch.ca

Akilen Rajadurai, PhD, BSc

416-340-4104arajadur@uhnresearch.ca

Locations

Toronto General Hospital

Recruiting

Toronto, Ontario, Canada, M5G 1Z5

Contacts

Johane P Allard, MD, FRCPC

416-340-5159johane.allard@uhn.on.ca

Anastasia Teterina, PhD

416-340-4104anastasia.teterina@uhnresearch.ca

Principal Investigator:

Johane Allard, MD,FRCPC

More Information

Sponsor

University Health Network, Toronto

Last update posted

Nov 2, 2022

Last verified

Nov, 2022

Keywords

  • NAFLD

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by University Health Network, Toronto on 2022-11-02.